web analytics

The Swedish Competition Authority approves Karo Pharma’s acquisition of Trimb and Karo Pharma continues the company’s efforts related to internalisation of sales and marketing

Karo Pharma Aktiebolag (the ”Company” or ”Karo Pharma”) today announces that the acquisition of all the shares of Trimb Holding AB (“Trimb”) from Avista Capital Partners (“Avista”) and other shareholders for MSEK 3,400 (the ”Transaction”), which was signed on 21 June, 2019, has been approved by the Swedish Competition Authority. Previously, clearances have been received from the competition authorities in Germany and Austria. The Transaction is expected to close on 12 September, 2019.

The decisions from the competition authorities entail that they approve the company concentration

Source: The Swedish Competition Authority approves Karo Pharma’s acquisition of Trimb and Karo Pharma continues the company’s efforts related to internalisation of sales and marketing

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.